aescuvest, a Germany based investment crowdfunding platform, announced a partnership with EIT Health as to launch the first pan-European equity crowdfunding platform for European healthcare companies.
The platform will give both, retail and institutional investors, access to best-in-class start-ups in segments such as biotechnology and medtech, a press release states. The start of the first campaign is expected in Q4 2018.
Dr Patrick Pfeffer, CEO & Founder of aescuvest said:
We are very proud to have been chosen by EIT Health as the partner for this trailblazing project, that is in itself innovative in the financing and crowdfunding sector. EIT Health activities are needs-driven and feature the engagement of future users and patients in the development, testing and scaling of solutions in co-creation environments. It is the goal of aescuvest.eu to build a bridge between European citizens, healthcare professionals and healthcare innovators.
Jan-Philipp Beck, CEO of EIT Health, added:
Crowdfunding stops at country borders these days. The cooperation with aescuvest.eu enables EIT Health to provide a unique service that will attract lots of start-ups and clearly differentiate us against any other accelerator. aescuvest.eu gives strong visibility, helps creating a bigger customer base, higher funding volume and therefore increased chances to succeed and to create impact. aescuvest’s specialisation, expert due diligence and excellent digital reach of professionals within the sector, combined with EIT Health’s incomparable access to hundreds of innovative companies, offers investors an exciting investment opportunity.
Find out more here.